STAT investigation: States’ efforts show drug cost isn't the biggest obstacle to eliminating hep C

Experts assumed the biggest obstacle to eliminating hep C was the sky-high cost of a cure. An investigation reveals more intractable issues. ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

With a promising new plan to pay for pricey cures, two states set out to eliminate hepatitis C. But cost hasn’t been the biggest problem By Nicholas Florko Experts assumed the biggest obstacle to eliminating hepatitis C was the sky-high cost of a new miracle cure. But an investigation into Washington's and Louisiana’s efforts reveals more intractable issues. Read More Sponsor content by STAT Events When the Barrier to a Breakthrough Drug is You Can’t Make It On Sept 28, hear how developers have approached the manufacturing process to bring new and innovative treatments to patients. Register for free. More great reads from STAT this week ‘This is pharma’s dream’: How drugmakers are turning telehealth into a marketing gold mine By Katie Palmer Complexity of Covid vaccine program leads to concerns about potential for error By Helen Branswell These 3 startups are trying to improve diversity in clinical trials, a challenge experts say will take more than just tech By Ambar Castillo The meth crisis is worse than ever, but new treatments might be around the corner By Lev Facher Savvier buyers threaten mental health tech’s momentum By Mario Aguilar Listen: A pediatric doctor on the life-or-death decisions some prospective parents must make By Patrick Skerrett Opinion: Don’t let shrill debates keep you from getting a Covid booster By Matthew Herper Experts urge Medicare to overhaul secretive panel that helps determine doctors’ pay By Bob Herman ‘How do we support each other?’: A physician and ethicist on the difficult decisions doctors now face in abortion care By Theresa Gaffney Saturday, September 17, 2022       1 Exchange Pl, Suite 201, Boston, MA 02109 ©2022, All Rights Reserved. I no longer wish to receive STAT emails Update Email Preferences | Contact Us | View In Browser